Experimental drug targets gene driving severe seizures in children
Researchers at the Fralin Biomedical Research Institute are developing a…
Researchers at the Fralin Biomedical Research Institute are developing a targeted KCNT1 inhibitor that has shown early promise in reducing seizures in preclinical models.